Interferon-gamma release assays testing versus tuberculosis skin testing for tuberculosis: a review of the clinical effectiveness and guidelines
Canadian Agency for Drugs and Technologies in Health
Record ID 32011000936
English
Authors' recommendations:
The evidence suggests that IGRA testing appears to be more specific than TST testing for identification of latent TB in individuals who have received the BCG vaccination or who are immunocompromised. The guidelines recommend IGRAs as a confirmatory test for people with a positive TST, or in individuals who are immunocompromised with a negative TST if a false-negative test is suspected.
Details
Project Status:
Completed
Year Published:
2011
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Immunoassay
- Interferon-gamma
- Sensitivity and Specificity
- Skin
- Tuberculin Test
- Immunologic Tests
- Tuberculosis
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.